Similar articles

• [Tobramycin: pharmacology in man].

  Brogard JM, Harf C, Pinget M, Lavillaureix J. Brogard JM, et al. Nouv Presse Med. 1974 Apr 27;3(0):59-64. Nouv Presse Med. 1974. PMID: 4600180 Clinical Trial. French. No abstract available.
• [A study of the cochleo-vestibular tolerance of tobramycin in man. Preliminary study].

  Brogard JM, Conraux C, Collard M, Jahn H, Lavillaureix J. Brogard JM, et al. Nouv Presse Med. 1974 Apr 27;3(0):75-9. Nouv Presse Med. 1974. PMID: 4600182 Clinical Trial. French. No abstract available.
• [Value of tobramycin in pediatrics. Apropos of 40 cases].

  Gilly R, Fougerat J. Gilly R, et al. Nouv Presse Med. 1974 Apr 27;3(0):72-4. Nouv Presse Med. 1974. PMID: 4599829 Clinical Trial. French. No abstract available.
• Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.

  Brogard JM, Comte F, Spach MO. Brogard JM, et al. Contrib Nephrol. 1984;42:182-95. Contrib Nephrol. 1984. PMID: 6398194 Review. No abstract available.
• Extended-interval aminoglycoside dosing in pediatrics.

  Jenh AM, Tamma PD, Milstone AM. Jenh AM, et al. Pediatr Infect Dis J. 2011 Apr;30(4):338-9. doi: 10.1097/INF.0b013e31820f0f3a. Pediatr Infect Dis J. 2011. PMID: 21407038 Review. No abstract available.